Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL31347292

N#Cc1cc2cc(Cl)cc(F)c2nc1Cl.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KHK P50053 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.37
▸ GPR35 Q9HC97 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ GPR6 P46095 2/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ KEAP1 Q14145 1/20 0.32
▸ NFE2L2 Q16236 1/20 0.32
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ GRM4 Q14833 1/20 0.31
▸ CNR2 P34972 1/20 0.31
▸ MAPKAPK2 P49137 1/20 0.31
▸ S1PR3 Q99500 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29875937 0.76 KHK (0.39) KHKALDH1A1GPR35CYP1A2CYP2C19
SCHEMBL29876818 0.73 KHK (0.39) KHKALDH1A1GPR35CYP1A2CYP2C9
SCHEMBL24610998 0.73 KHK (0.50) KHKALDH1A1GPR35CYP1A2CYP2C9
SCHEMBL30198252 0.71 KEAP1 (0.59) ALDH1A1GPR35CYP1A2CYP2C9SMN1; SMN2
SCHEMBL29876208 0.71 KHK (0.37) KHKALDH1A1GPR35
SCHEMBL29876035 0.71 IDH1 (0.43) KHKALDH1A1
SCHEMBL29876356 0.70 KHK (0.36) KHKALDH1A1GPR35NPSR1CNR2
SCHEMBL29877049 0.70 KHK (0.36) KHKALDH1A1GPR35SMN1; SMN2
SCHEMBL29876316 0.69 KHK (0.36) KHKGPR35SMN1; SMN2MAPKAPK2
SCHEMBL16390953 0.68 KHK (0.51) KHKALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119119085-A Substituted pyrimido ring inhibitor and preparation method and application thereof 苏州泽璟生物制药股份有限公司 2024-12-13 — — CN disclosed
Send feedback